APOM

From Wikipedia, the free encyclopedia


Apolipoprotein M
Identifiers
Symbol(s) APOM; G3a; HSPC336; MGC22400; NG20
External IDs OMIM: 606907 MGI1930124 HomoloGene10308
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 55937 55938
Ensembl ENSG00000204444 ENSMUSG00000024391
Uniprot O95445 Q8VC79
Refseq NM_019101 (mRNA)
NP_061974 (protein)
NM_018816 (mRNA)
NP_061286 (protein)
Location Chr 6: 31.73 - 31.73 Mb Chr 17: 34.74 - 34.74 Mb
Pubmed search [1] [2]

Apolipoprotein M, also known as APOM, is a human gene.[1]

The protein encoded by this gene is an apolipoprotein and member of the lipocalin protein family. It is found associated with high density lipoproteins and to a lesser extent with low density lipoproteins and triglyceride-rich lipoproteins. The encoded protein is secreted through the plasma membrane but remains membrane-bound, where it is involved in lipid transport. Two transcript variants encoding two different isoforms have been found for this gene, but only one of them has been fully characterized.[1]

[edit] References

[edit] Further reading

  • Albertella MR, Jones H, Thomson W, et al. (1997). "Localization of eight additional genes in the human major histocompatibility complex, including the gene encoding the casein kinase II beta subunit (CSNK2B).". Genomics 36 (2): 240–51. doi:10.1006/geno.1996.0459. PMID 8812450. 
  • Xu N, Dahlbäck B (1999). "A novel human apolipoprotein (apoM).". J. Biol. Chem. 274 (44): 31286–90. PMID 10531326. 
  • Duan J, Dahlbäck B, Villoutreix BO (2001). "Proposed lipocalin fold for apolipoprotein M based on bioinformatics and site-directed mutagenesis.". FEBS Lett. 499 (1-2): 127–32. PMID 11418126. 
  • Xu N, Zhang XY, Dong X, et al. (2002). "Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells.". Biochem. Biophys. Res. Commun. 292 (4): 944–50. doi:10.1006/bbrc.2002.6755. PMID 11944906. 
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932. 
  • Zhang XY, Dong X, Zheng L, et al. (2003). "Specific tissue expression and cellular localization of human apolipoprotein M as determined by in situ hybridization.". Acta Histochem. 105 (1): 67–72. PMID 12666989. 
  • Mungall AJ, Palmer SA, Sims SK, et al. (2003). "The DNA sequence and analysis of human chromosome 6.". Nature 425 (6960): 805–11. doi:10.1038/nature02055. PMID 14574404. 
  • Richter S, Shih DQ, Pearson ER, et al. (2004). "Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels.". Diabetes 52 (12): 2989–95. PMID 14633861. 
  • Xie T, Rowen L, Aguado B, et al. (2004). "Analysis of the gene-dense major histocompatibility complex class III region and its comparison to mouse.". Genome Res. 13 (12): 2621–36. doi:10.1101/gr.1736803. PMID 14656967. 
  • Zhang XY, Jiao GQ, Hurtig M, et al. (2005). "Expression pattern of apolipoprotein M during mouse and human embryogenesis.". Acta Histochem. 106 (2): 123–8. doi:10.1016/j.acthis.2003.11.004. PMID 15147633. 
  • Kabbara A, Payet N, Cottel D, et al. (2004). "Exclusion of CYP46 and APOM as candidate genes for Alzheimer's disease in a French population.". Neurosci. Lett. 363 (2): 139–43. doi:10.1016/j.neulet.2004.03.066. PMID 15172102. 
  • Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334. 
  • Xu N, Nilsson-Ehle P, Ahrén B (2005). "Correlation of apolipoprotein M with leptin and cholesterol in normal and obese subjects.". J. Nutr. Biochem. 15 (10): 579–82. doi:10.1016/j.jnutbio.2004.03.001. PMID 15542348. 
  • Luo G, Hurtig M, Zhang X, et al. (2005). "Leptin inhibits apolipoprotein M transcription and secretion in human hepatoma cell line, HepG2 cells.". Biochim. Biophys. Acta 1734 (2): 198–202. doi:10.1016/j.bbalip.2005.02.005. PMID 15904876. 
  • Liu T, Qian WJ, Gritsenko MA, et al. (2006). "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.". J. Proteome Res. 4 (6): 2070–80. doi:10.1021/pr0502065. PMID 16335952. 
  • Niu N, Zhu X, Liu Y, et al. (2007). "Single nucleotide polymorphisms in the proximal promoter region of apolipoprotein M gene (apoM) confer the susceptibility to development of type 2 diabetes in Han Chinese.". Diabetes Metab. Res. Rev. 23 (1): 21–5. doi:10.1002/dmrr.641. PMID 16572495. 
  • Christoffersen C, Nielsen LB, Axler O, et al. (2006). "Isolation and characterization of human apolipoprotein M-containing lipoproteins.". J. Lipid Res. 47 (8): 1833–43. doi:10.1194/jlr.M600055-JLR200. PMID 16682745. 
  • Karlsson H, Lindqvist H, Tagesson C, Lindahl M (2006). "Characterization of apolipoprotein M isoforms in low-density lipoprotein.". J. Proteome Res. 5 (10): 2685–90. doi:10.1021/pr060180x. PMID 17022639. 
  • Xu X, Ye Q, Xu N, et al. (2007). "Effects of ischemia-reperfusion injury on apolipoprotein M expression in the liver.". Transplant. Proc. 38 (9): 2769–73. doi:10.1016/j.transproceed.2006.08.133. PMID 17112825. 
  • Ahnström J, Faber K, Axler O, Dahlbäck B (2007). "Hydrophobic ligand binding properties of the human lipocalin apolipoprotein M.". J. Lipid Res. 48 (8): 1754–62. doi:10.1194/jlr.M700103-JLR200. PMID 17525477.